Evidence map›Paper›PMID 32220004›Full record

ArticleJournal of cellular and molecular medicine2020

Intestinal fatty acid-binding protein mediates atherosclerotic progress through increasing intestinal inflammation and permeability.

Lulu Zhang, Fan Wang, Jiajun Wang, Yongshun Wang, Yan Fang

RetractedOpen access · goldAbstract readRetracted Publication
In one paragraph

Article in Journal of cellular and molecular medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
2.1field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Article
  3. A study on the treatment effects ofFrontiers in veterinary science · 2024
    Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Role and Mechanism of Gut Microbiota in Human Disease.Frontiers in cellular and infection microbiology · 2021
    Review
  17. Intestinal barrier dysfunction as a therapeutic target for cardiovascular disease.American journal of physiology. Heart and circulatory physiology · 2020
    Review
  18. Review
  19. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Lulu ZhangDepartment of Cardiology, 2nd Affiliated Hospital of Harbin Medical University, Harbin, China.
Fan WangDepartment of Cardiology, 2nd Affiliated Hospital of Harbin Medical University, Harbin, China.
Jiajun WangDepartment of Cardiology, 2nd Affiliated Hospital of Harbin Medical University, Harbin, China.
Yongshun WangDepartment of Cardiology, 2nd Affiliated Hospital of Harbin Medical University, Harbin, China.
Yan FangDepartment of Cardiology, 2nd Affiliated Hospital of Harbin Medical University, Harbin, China.ORCID 0000-0001-5765-1240
Harbin Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Atherosclerosis is one of leading phenotypes of cardiovascular diseases, featured with increased vascular intima-media thickness (IMT) and unstable plaques. The interaction between gastrointestinal system and cardiovascular homeostasis is emerging as a hot topic. Therefore, the present study aimed to explore the role of an intestinal protein, intestinal fatty acid-binding protein (I-FABP/FABP2) in the atherosclerotic progress. In western diet-fed ApoE

Indexed as

Disease ProgressionAnimalsApolipoproteins EAtherosclerosisCholesterolDiet, High-FatFatty Acid-Binding ProteinsGene Knockdown TechniquesInflammationMaleMice, KnockoutPermeabilityApolipoproteins ECholesterolFatty Acid-Binding Proteinsatherosclerosisinflammationintestinal fatty acid-binding proteinintestinal permeability

Identifiers

PMID32220004
PMCPMC7205806
OpenAlexW3013343344

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.